1. 525 SURGICAL MORBIDITY AND MORTALITY FROM THE NEORESII TRIAL: STANDARD VS. PROLONGED TIME TO SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER. (14th September 2020) Authors: Nilsson, K; Klevebro, F; Rouvelas, I; Lindblad, M; Szabo, E; Halldestam, I; Smedh, U; Wallner, B; Johansson, J; Johnsen, G; Kjus Ahlin, E; Johannessen, H; Hjortland, G; Bartella, I; Schröder, W; Bruns, C; Nilsson, M Journal: Diseases of the esophagus Issue: Volume 33(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗